INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845PAB4 Class: CONV BD US

Calamos Advisors LLC's Holding History (CIK: 0001316507)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 5,000,000 Value ($000) $4,903 Avg Close — Range —
Q2 2023
Shares 5,000,000 Value ($000) $3,998 Avg Close — Range —
Q1 2023
Shares 5,000,000 Value ($000) $4,157 Avg Close — Range —
Q4 2022
Shares 5,000,000 Value ($000) $3,784 Avg Close — Range —
Q3 2022
Shares 5,000,000 Value ($000) $3,777 Avg Close — Range —
Q2 2022
Shares 5,000,000 Value ($000) $3,209 Avg Close — Range —
Q1 2022
Shares 5,000,000 Value ($000) $3,068 Avg Close — Range —
Q4 2021
Shares 5,000,000 Value ($000) $3,012 Avg Close — Range —
Q3 2021
Shares 5,000,000 Value ($000) $3,030 Avg Close — Range —
Q2 2021
Shares 5,000,000 Value ($000) $3,421 Avg Close — Range —
Q1 2021
Shares 5,000,000 Value ($000) $3,220 Avg Close — Range —
Q4 2020
Shares 5,000,000 Value ($000) $3,036 Avg Close — Range —
Q3 2020
Shares 5,000,000 Value ($000) $3,465 Avg Close — Range —
Q2 2020
Shares 5,000,000 Value ($000) $3,602 Avg Close — Range —
Q1 2020
Shares 5,000,000 Value ($000) $4,345 Avg Close — Range —
Q4 2019
Shares 5,000,000 Value ($000) $6,649 Avg Close — Range —
Q3 2019
Shares 5,000,000 Value ($000) $4,537 Avg Close — Range —
Q2 2019
Shares 5,000,000 Value ($000) $4,998 Avg Close — Range —